Been climbing steadily up toward .40 (US) on higher volume as warrants are shaken out and FDA approval for Pennsaid nears on August 5th. The company has already been paid 10 million by Covidien and stand to make much more when FDA approval comes. Covidien will also carry the full costs of clinical trials for Pennsaid Plus, slated to commence in 2010.
It's also important to note that they've also received an "approvable letter" from the FDA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.